Quick Dispatch:
Your tirzepatide hfpef Tirzepatide for HFpEF and Obesity: Breakthrough or Overhyped? (SUMMIT) | NEJM orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your tirzepatide hfpef Tirzepatide for HFpEF and Obesity: Breakthrough or Overhyped? (SUMMIT) | NEJM ships.
Need Help?
Questions about tirzepatide hfpef Tirzepatide for HFpEF and Obesity: Breakthrough or Overhyped? (SUMMIT) | NEJM, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for tirzepatide hfpef Tirzepatide for HFpEF and Obesity: Breakthrough or Overhyped? (SUMMIT) | NEJM in your area.
🎙️ Rounds Table — Infographics Now Live! 📊 Featured trials: 🩸 HI-PRO – Apixaban for extended treatment of provoked VTE 🫀 SUMMIT – Tirzepatide for HFpEF with obesity 💊 AQUATIC – Aspirin
22.25
Influence of Type 2 Diabetes on the Effects of Tirzepatide in Patients With Heart Failure and a Preserved Ejection Fraction With Obesity: A Prespecified Stratification-Based Analysis
26.45
In pts wiht HFpEF and obesity, tirzepatide (Mounjaro®) significantly reduces HF hospitalization, diuretic intensification, or CV death by 38% vs placebo in SUMMIT trial https://t.co/8ZHm4gySiL
24.70
GitHub
24.61
Tirzepatide Helps in HFpEF Across Spectrum of Obesity Severity
21.51
A new Brief Report in the Journal of Cardiac Failure compares tirzepatide (GIP/GLP-1) and semaglutide (GLP-1) in patients with HFpEF and type 2 diabetes. In this analysis, there were no significant differences
29.60
In patients with cardiometabolic #HFpEF, #semaglutide and #tirzepatide reduced the risk of hospitalization for heart failure or all-cause mortality compared to sitagliptin, but tirzepatide offered no additional benefit over semaglutide. https://ja.ma
29.67
